ILYANG PHARMACEUTICAL (007570) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, ILYANG PHARMACEUTICAL (007570) reported revenue of 272.4 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025272.4 billion KRW5.0 billion KRW7.1 billion KRW[source]
2024268.9 billion KRW11.0 billion KRW10.5 billion KRW[source]
2023266.7 billion KRW16.4 billion KRW-2.0 billion KRW[source]
2022247.8 billion KRW14.2 billion KRW19.8 billion KRW[source]
2021371.3 billion KRW41.0 billion KRW26.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025415.1 billion KRW214.9 billion KRW200.2 billion KRW[source]
2024389.6 billion KRW187.8 billion KRW201.7 billion KRW[source]
2023356.7 billion KRW160.3 billion KRW196.4 billion KRW[source]
2022348.8 billion KRW159.2 billion KRW189.5 billion KRW[source]
2021371.8 billion KRW184.7 billion KRW187.0 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice